|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Current assets: | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Restricted cash | ||||||||||||||||
| Cash | ||||||||||||||||
| Accounts receivable, net | ||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||
| Escrow deposit | ||||||||||||||||
| Total current assets | ||||||||||||||||
| Property and equipment, net | ||||||||||||||||
| Right of use assets, net | ||||||||||||||||
| Intangible assets, net | ||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||
| Goodwill | ||||||||||||||||
| Other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||
| Current liabilities: | ||||||||||||||||
| Accounts payable | ||||||||||||||||
| Accrued liabilities | ||||||||||||||||
| Deferred revenue | ||||||||||||||||
| Current portion of debt, net of debt issuance costs | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| Long-term debt, net of debt issuance costs | ||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||
| Long-term deferred revenue | ||||||||||||||||
| Deferred rent | ||||||||||||||||
| Other long-term liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Stockholders’ Equity: | ||||||||||||||||
| Preferred stock, $0.001 par value; 50,000,000 shares authorized; zero shares issued and outstanding at June 30, 2025 and December 31, 2024 | ||||||||||||||||
| Common stock, $0.001 par value; 600,000,000 shares authorized, 74,195,939 and 76,049,681 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||
Loading...
